当前位置: X-MOL 学术Asian Pac. J. Allergy Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Long-term effectiveness of omalizumab treatment in Thai severe asthmatic patients: A real-life experience.
Asian Pacific Journal of Allergy and Immunology ( IF 5 ) Pub Date : 2017-11-22 , DOI: 10.12932/ap0872
Theerasuk Kawamatawong 1 , Orapan Poachanukoon 2 , Chalermporn Boonsiri 3 , Atik Saengasapaviriya 4 , Atik Saengasapaviriya 4 , Chanchai Sittipunt 5 , Hiroshi Chantaphakul 6 , Atik Saengasapaviriya 4 , Kittipong Maneechotesuwan 7 , Pintip Ngamchanyaporn 8 , Kunchit Piyavechviratana 9 , Praparn Yongjaiyut 7 , Apichart Khanisap 2 , Siwasak Juthong 10 , Warangkana Rithirak 10 , Prapaporn Pornsuriyasak 1 , Chaicharn Pothirat 11 , Watchara Boonsawat 12, 13
Affiliation  

To evaluate long-term effectiveness of omalizumab in 'real-life' setting of Thai asthmatic patients.

中文翻译:

omalizumab治疗在泰国严重哮喘患者中的长期有效性:真实经验。

为了评估omalizumab在泰国哮喘患者“真实生活”中的长期有效性。
更新日期:2020-08-21
down
wechat
bug